Hideyuki Muramatsu - Concepedia

Author

Hideyuki Muramatsu

Astellas Pharma (Japan)ORCID

Also Known As

H. Muramatsu, HIDEYUKI MURAMATSU, Hideyuki MURAMATSU, Hideyuki Muramatsu, Hideyuki Takimura Toshiya Muramatsu

Publications

906

Citations

H-Index

Concepts

All Affiliations

Astellas Pharma (Japan)Fujisawa City Hospital The University of Tokyo Showa University Technology Centre Prague

About

Hideyuki Muramatsu is an author at Astellas Pharma (Japan) specializing in medicine, microbiology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	456
2	Natural Sciences	5	5	79
3	Engineering	1	1	59
4	Health Sciences	1	1	10
5	Anatomy	1	1	17

Hideyuki Muramatsu

Publications

825

Citations

H-Index

Page 1

	Year	Citations
Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12 Takeshi Hosaka, Mayumi Ohnishi‐Kameyama, Hideyuki Muramatsu, Nature Biotechnology Antimicrobial Drug DiscoveryBacteriologyRna PolymeraseMolecular BiologyAntibacterial Discovery	2009	237
Acquisition of Certain Streptomycin-Resistant (<i>str</i>) Mutations Enhances Antibiotic Production in Bacteria Y Hosoya, Susumu Okamoto, Hideyuki Muramatsu, Antimicrobial Agents and Chemotherapy	1998	113
A New Antimitotic Substance, FR182877. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities. Bunji Sato, Hideyuki Muramatsu, MICHIYO MIYAUCHI, The Journal of Antibiotics	2000	91
Vulgatibacter incomptus gen. nov., sp. nov. and Labilithrix luteola gen. nov., sp. nov., two myxobacteria isolated from soil in Yakushima Island, and the description of Vulgatibacteraceae fam. nov., Labilitrichaceae fam. nov. and Anaeromyxobacteraceae fam. nov. Eisaku Yamamoto, Hideyuki Muramatsu, Koji Nagai INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY Myxobacterial StrainsGen. Nov.Pathogenic MicrobiologyEngineeringBacteriology	2014	59
FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Properties. Akihiko Fujie, TOSHIRO IWAMOTO, Hideyuki Muramatsu, The Journal of Antibiotics	2000	57
Surgical treatment of facial fracture by using unsintered hydroxyapatite particles/poly l-lactide composite device (OSTEOTRANS MX®): A clinical study on 17 cases Minoru Hayashi, Hideyuki Muramatsu, Masahide Sato, Journal of Cranio-Maxillofacial Surgery HydroxyapatiteSurgical TreatmentMedicineFacial FractureFracture Healing	2013	43
FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243. II. In Vitro and In Vivo Activities. Akihiko Fujie, TOSHIRO IWAMOTO, Hideyuki Muramatsu, The Journal of Antibiotics	2000	32
Experience of Using Cultured Epithelial Autografts for the Extensive Burn Wounds in Eight Patients Minoru Hayashi, Hideyuki Muramatsu, Minoru Nakano, Annals of Plastic Surgery	2014	28
Streptomyces tsukubensis sp. nov., a producer of the immunosuppressant tacrolimus Hideyuki Muramatsu, Koji Nagai The Journal of Antibiotics MedicineImmunologyMicrobiologyStreptomyces Tsukubensis Sp	2013	24
FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties Akihiko Fujie, TOSHIRO IWAMOTO, Bunji Sato, Bioorganic & Medicinal Chemistry Letters Lipid PreparationBioorganic ChemistryBiochemistryNatural SciencesMedicine	2001	21

Page 1